RE:RE:Other regional deals could follow quicklyThe rest of the world outside of China is still available.
I think we're going to see regional deals that cover any clinical development costs in the regions like the Hepalink deal and that allow regional development in multiple juristictions as rapidly as possible. At the BIO Conference Don said regional deals would allow parallel development accelerating tim eot market. He outlined the regions of China, the Middle East, and Russia and the disease burden. We've now got Hepalink for China. We could also see a European deal given the Phase III approval. The prize US deal could wait until trials are completed to maximize the royalty rate. RVX has funding now to support US trials including for orphan indications.